1 – 14 of 14
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States
(
- Contribution to journal › Article
- 2014
-
Mark
Decision-Analytic Models: Current Methodological Challenges
(
- Contribution to journal › Article
- 2012
-
Mark
Economic Evaluation of Smoking-Cessation Therapies: A Critical and Systematic Review of Simulation Models.
(
- Contribution to journal › Scientific review
-
Mark
The Cost Effectiveness of Newer Epilepsy Treatments: A Review of the Literature on Partial-Onset Seizures.
(
- Contribution to journal › Scientific review
- 2011
-
Mark
Economic value of smoking cessation therapies: a critical and systematic review of simulation-generated evidence
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Estimating the Cost of Diabetes Mellitus-Related Events from Inpatient Admissions in Sweden Using Administrative Hospitalization Data
(
- Contribution to journal › Article
- 2005
-
Mark
Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone
(
- Contribution to journal › Article
- 2004
-
Mark
Why did drug spending increase during the 1990s?: a decomposition based on Swedish data.
(
- Contribution to journal › Article
-
Mark
Assessing the use of retrospective databases in conducting economic evaluations of drugs : the case of asthma
(
- Contribution to journal › Scientific review
-
Mark
Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden - An economic evaluation based on the MORE study
(
- Contribution to journal › Article
- 2003
-
Mark
Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures.
(
- Contribution to journal › Article
-
Mark
Cost effectiveness of nasal budesonide versus surgical treatment for nasal polyps
(
- Contribution to journal › Article
- 2000
-
Mark
Pharmaeconomics and clinical practice guidelines
(
- Contribution to journal › Article
- 1997
-
Mark
Cost-effective treatment of uncomplicated gonorrhoea including co-infection with Chlamydia trachomatis
(
- Contribution to journal › Article